4CPS-036 Analysis of pharmacotherapeutic interventions at emergency department

<h3>Background and Importance</h3> The severity and instability of patients, together with the high degree of medication complexity, make the Emergency Room (ER) a critical area of medication related problems. <h3>Aim and Objectives</h3> The aim of our study was to analyse and evaluate the clinical activity performed by the resident clinical pharmacist in the ER team. <h3>Material and Methods</h3> A descriptive, prospective, 8-week study. The pharmacist joined the ER multidisciplinary team. Pharmacotherapeutic interventions (PIs) performed and the degree of acceptance were recorded. <h3>Results</h3> We recorded 338 PIs on 187 patients with a 75% acceptance rate. Most of the PIs were omission of baseline treatment (53%), other interventions (14%), change in posology (13%), suspension of treatment (13%) and initiation of new treatment (7%). An 18% of patients were interviewed. Of the PIs accepted, a 65% influenced the efficacy and 35% the safety of the treatment. The drugs that have been susceptible to generate more actions have been N-Nervous (35%), C-Cardiovascular (24%), A-Digestive apparatus and metabolism (12%), J-Anti-infectious (10%), B-Blood (9%), H-Systemic hormonal preparations (6%), R-Respiratory system (3%), and L-Antineoplastic agents and immunomodulators (2%). The medical specialties that were most susceptible to intervention were Surgery, Internal Medicine, Cardiology and Digestive. <h3>Conclusion and Relevance</h3> Most PIs are related to drugs of the nervous and cardiovascular systems and the most frequent type of PI is medication reconciliation due to unjustified omissions of the patient‘s baseline treatment. The clinical pharmacist integrated in the multidisciplinary ER team can add value to the pharmacotherapeutic process of the emergency patient. <h3>References and/or Acknowledgements</h3> <h3>Conflict of Interest</h3> No conflict of interest